Evidence map›Paper›PMID 37683139›Full record

ArticleBlood2023

Follicular lymphoma evolves with a surmountable dependency on acquired glycosylation motifs in the B-cell receptor.

Sarah Haebe, Grady Day, Debra K Czerwinski, Anuja Sathe, Susan M Grimes, Tianqi Chen, Steven R Long, Brock Martin, Michael G Ozawa, Hanlee P Ji and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Sarah HaebeDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
Grady DayDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.ORCID 0000-0001-9150-1182
Debra K CzerwinskiDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
Anuja SatheDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.ORCID 0000-0002-2100-0013
Susan M GrimesStanford Genome Technology Center, Stanford University, Stanford, CA.
Tianqi ChenDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
Steven R LongDepartment of Pathology, University of California, San Francisco, CA.
Brock MartinDepartment of Pathology, Stanford University School of Medicine, Stanford, CA.
Michael G OzawaDepartment of Pathology, Stanford University School of Medicine, Stanford, CA.
Hanlee P JiDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
Tanaya ShreeDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.ORCID 0000-0003-0694-3512
Ronald LevyDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
Stanford University · USUniversity of California, San Francisco · US

Funding

Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the HostR35CA197353 · NCI · STANFORD UNIVERSITY · PI LEVY, RONALD · 2016 to 2022
$6.1M
Statistical Models for Genome Sequencing and AssociationR01HG006137 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI JI, HANLEE P, ZHANG, NANCY R · 2011 to 2022
$4.3M
Dynamic Analysis of Tumor and Microenvironment in Patients Undergoing ImmunotherapyK08CA252637 · NCI · STANFORD UNIVERSITY · PI SHREE, TANAYA · 2020 to 2024
$947k
NCI NIH HHS K08 CA252637NCI NIH HHS R35 CA197353NHGRI NIH HHS R01 HG006137
6 · The paper itself

Abstract

abstractAn early event in the genesis of follicular lymphoma (FL) is the acquisition of new glycosylation motifs in the B-cell receptor (BCR) due to gene rearrangement and/or somatic hypermutation. These N-linked glycosylation motifs (N-motifs) contain mannose-terminated glycans and can interact with lectins in the tumor microenvironment, activating the tumor BCR pathway. N-motifs are stable during FL evolution, suggesting that FL tumor cells are dependent on them for their survival. Here, we investigated the dynamics and potential impact of N-motif prevalence in FL at the single-cell level across distinct tumor sites and over time in 17 patients. Although most patients had acquired at least 1 N-motif as an early event, we also found (1) cases without N-motifs in the heavy or light chains at any tumor site or time point and (2) cases with discordant N-motif patterns across different tumor sites. Inferring phylogenetic trees of the patients with discordant patterns, we observed that both N-motif-positive and N-motif-negative tumor subclones could be selected and expanded during tumor evolution. Comparing N-motif-positive with N-motif-negative tumor cells within a patient revealed higher expression of genes involved in the BCR pathway and inflammatory response, whereas tumor cells without N-motifs had higher activity of pathways involved in energy metabolism. In conclusion, although acquired N-motifs likely support FL pathogenesis through antigen-independent BCR signaling in most patients with FL, N-motif-negative tumor cells can also be selected and expanded and may depend more heavily on altered metabolism for competitive survival.

Indexed as

Lymphoma, FollicularGlycosylationHumansLectinsPhylogenyReceptors, Antigen, B-CellTumor MicroenvironmentLectinsReceptors, Antigen, B-Cell

Identifiers

PMID37683139
PMCPMC10797552
OpenAlexW4386533160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.